CompletedPhase 2NCT03142568
Safety of Sildenafil in Premature Infants
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of North Carolina, Chapel Hill
- Principal Investigator
- Matthew M Laughon, MD, MPHUniversity of North Carolina, Chapel Hill
- Intervention
- Sildenafil(drug)
- Enrollment
- 109 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2025
Study locations (15)
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- University of Florida College of Medicine Jacksonville-Wolfson Children's Hospital, Jacksonville, Florida, United States
- University of Florida Jacksonville Shands Medical Center, Jacksonville, Florida, United States
- University of Illinois at Chicago, Chicago, Illinois, United States
- Wesley Medical Center, Wichita, Kansas, United States
- University of Kentucky, Lexington, Kentucky, United States
- Ochsner Baptist Medical Center, New Orleans, Louisiana, United States
- University of Mississippi Medical Center, Jackson, Mississippi, United States
- Children's Hospital of Nevada at UMC, Las Vegas, Nevada, United States
- Monmouth Medical Center, Long Branch, New Jersey, United States
- Cohen Children's Medical Center of NY, New Hyde Park, New York, United States
- Golisano Children's Hospital - University of Rochester Medical Center, Rochester, New York, United States
- WakeMed Health and Hospitals, Raleigh, North Carolina, United States
- University of Oklahoma, Oklahoma City, Oklahoma, United States
- Health Sciences Centre Hospital, Winnipeg, Manitoba, Canada
Collaborators
Duke University · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · The Emmes Company, LLC
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03142568 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGNCT07134387Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)Global Foundation for the Care of Newborn Infants